HORIBA, Ltd. (HRIBF)
PNK · Technology · Scientific & Technical Instruments
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About HORIBA, Ltd.
HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutions for water and liquid, industrial process, and energy. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising health care, fluid control, mass spectrometry, spectroscopy, microscopy and imaging, electrochemistry, physisorption, particle and element analysis, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.
Quarterly Financials
| Metric | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Diluted EPS | $192.40 | $206.12 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 270.1B | 290.6B | 317.4B | 333.1B |
| Gross Profit | 116.7B | 127.4B | 136.9B | 146.4B |
| Operating Income | 45.8B | 47.3B | 48.3B | 53.0B |
| Net Income | 34.1B | 40.3B | 33.6B | 37.1B |
| Diluted EPS | $802.89 | $948.83 | $795.34 | $879.27 |